Healthcare Empowered: Vim Launches Care Insights for Smarter, Data-Driven Decisions Vim, a leader in connected healthcare technology and clinical workflow integration, has announced the launch of Care Insights, a revolutionary…
Massive Bio Recognized by White House Cancer Moonshot, Launches $15M Initiative at JPM 2025 Massive Bio is proud to announce its inclusion in the White House Office of Science &…
Reports Positive Results from RESTORE Trial of ReActiv8® by Mainstay Medical Mainstay Medical Holdings plc reports today the publication of positive one-year results from the RESTORE randomized clinical trial of…
GenSight Biologics Announces Groundbreaking 5-Year Outcomes for Unilateral LUMEVOQ® Gene Therapy GenSight Biologics (Euronext: SIGHT) has announced the publication of five-year follow-up data for patients treated with its investigational gene…
Results: Castle Biosciences Reports Preliminary Q4 and 2024 Performance Castle Biosciences, Inc. (Nasdaq: CSTL), a company dedicated to improving patient care through innovative tests, today announced preliminary unaudited performance results…
Cigna Foundation Grants Support Veterans’ Mental Health and Housing The Cigna Group Foundation recently announced the 22 recipients for its inaugural year of a new grant program designed to support…
City Therapeutics Teams Up with Bausch + Lomb on RNAi Treatment for Geographic Atrophy City Therapeutics, Inc., a biopharmaceutical leader in RNA interference (RNAi)-based medicine, has announced a strategic collaboration…
Free Testosterone Test: Revvity Receives FDA Clearance for First Automated Assay Revvity, Inc. (NYSE: RVTY), a global leader in health science solutions, has announced that it has received 510(k) clearance…
Pulse Biosciences Appoints Paul LaViolette as CEO Pulse Biosciences, Inc. (Nasdaq: PLSE), a leader in bioelectric medicine utilizing its cutting-edge Nanosecond Pulsed Field Ablation™ (nano-PFA™) technology, today announces the appointment…
Heidelberg Engineering’s ANTERION® Gets FDA Clearance for Epithelial Thickness Module Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, has announced the FDA clearance of its Epithelial…
Clinical Progress and Business Updates in Oncology Pipeline Reported by Nimbus Therapeutics Nimbus Therapeutics, a biotechnology company leveraging its advanced computational drug discovery engine to develop breakthrough medicines, today announced…
Reports Complete Response in First Infant with ECUR-506 for OTC Deficiency, iECURE iECURE, Inc., a gene-editing company focused on developing in vivo gene insertion therapies for liver disorders, reports promising…